Genalyte | GenomeWeb

Genalyte

The company said this week that is has raised $36 million in funding, as it continues efforts to develop its Maverick platform for rapid testing in doctors' offices.

The company said it will use the funds to further refine its Maverick Detection System for rapid blood testing in outpatient settings like doctors' offices.

The company is preparing a clinical study through which it will collect data that it will use to submit the device to FDA for 510(k) clearance next year.

The San Diego diagnostics firm's technology is designed for rapid, multiplexed, blood-based testing in a physician's office setting.

Three collaborators will further explore the clinical usefulness of a TAA panel in early cancer detection and measuring response to cancer immunotherapy.

The test would allow healthcare workers to differentiate Ebola from other diseases that mimic the virus, a trait which presented problems during the recent crisis in West Africa. 

NEW YORK (GenomeWeb News) – The National Cancer Institute has awarded Genalyte a $1 million Small Business Innovation Research grant to develop a biomarker panel to profile tumor antigen-associated antibodies, Genalyte said today.

After announcing last month the release of its type 1 diabetes antigen panel, Genalyte is now planning to develop an expanded version of the research-use assay with collaborators at the University of Colorado's Barbara Davis Diabetes Center.

Biognosys has launched a new spectral library generation service designed to build spectral libraries for use with data-independent acquisition mass spec techniques like SWATH.

NEW YORK (GenomeWeb News) – Genalyte today said that it has inked an agreement with the Barbara Davis Center for Childhood Diabetes at the University of Colorado School of Medicine to collaborate on the further development of multiplexed antigen panels for the early detection of T1D.

Pages

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.